AS and ASH HCM_Naidu_updated.png

Reported in 2018 by anesthesiologists at the University of Florida College of Medicine in Gainesville, the case suggested a message to TAVR operators: “Vigilance and a high degree of suspicion” are critical for avoiding the potentially severe hemodynamic consequences of HCM associated with aortic stenosis, the authors asserted (J Med Case Rep 2018;18;12[1]:372).

Until recently, cardiologists’ eyes tended to glaze over at the mention of using 3D printing in their practices. Most believed the costs would be too high for routine use, that the applications and the price tag were better suited to academic applications.


To get the operational perspective, CVB hosted a roundtable discussion with service line leaders about the opportunities and challenges they encounter around data.


Experienced dyad and triad partners share tips for setting the stage for success and putting the brakes on mistakes.

Tom Giangiulio

As many as 700 hearts from donors with hepatitis C are discarded each year in the U.S. New research suggests at least some of these organs may be suitable for transplant.


Following data supporting their use for heart failure and type 2 diabetes, will sodium-glucose cotransporter 2 inhibitors find a spot in the heart failure armamentarium?


As use of cannabis products increases and evidence of possible cardiovascular harm mounts, it’s time for cardiologists to start having conversations with their patients.


Forward-looking providers are converting reams of data from myriad sources into innovative new ways to deliver healthcare and improve efficiencies.


Multidisciplinary teams are leveraging advanced technologies to explore the link between cardiovascular disease and dementia with an eye toward improving the diagnosis and treatment of both. 


In this first magazine of the 2020s, CVB invites the cardiology community to consider new mindsets for a number of areas, from treating dementias to tackling authorizations, documentation and collections. 


Here at CVB, we tend to think of our audience as cardiology’s practitioners, not its patients. But the truth is, the public is reading our content as frequently as physicians. Our job is the same, no matter the audience—to tell cardiology’s stories.


Performance Report: The Critical Characteristics of High-performing Cardiology Programs

Around the web

Gadolinium might be an alternative, stop-gap solution for interventional procedures during the current iodine contrast shortage.

Alan H. Matsumoto, MD, chair of the department of radiology at the University of Virginia and vice chair of the American College of Radiology Board of Chancellors, explains the contrast shortage situation and the tough decisions providers are being forced to make.

Alan H. Matsumoto, MD, chair of the department of radiology at the University of Virginia, vice chair of the American College of Radiology (ACR) Board of Chancellors, and chairman of the ACR Commission on Interventional and Cardiovascular Radiology, explains that the iodine contrast shortage has led to use of MRI gadolinium contrast agents in some cases.